Therapeutic antibody discovery for immunological and inflammation diseases empowered with Biocytogen’s fully human antibody platforms
Speaker: Dr. W. Frank An Sr. Director of Antibody Therapeutics Immunologic and inflammatory (I&I) diseases, including autoimmune conditions, affect more than 10% of the global population. Despite recent significant clinical advances in disease management, considerable unmet medical needs remain, and more effective, safer therapeutics are critically needed. Biocytogen’s antibody discovery platform leverages the fully human […]
Read more
Application of HLA-Humanized Mice in Preclinical Research
Speaker: Dr. Leila Kokabee Associate Director, In Vitro/Ex Vivo/Flow Cytometry Platform Leader HLA (Human Leukocyte Antigen) genes are critical components of the immune system, enabling it to distinguish between the body’s own cells and foreign invaders. Variations in HLA genes affect immune responses and influence susceptibility to autoimmune diseases, making them essential targets in immunology […]
Read more
Exploring Fully Human Nanobodies for Innovative Disease Treatments
Speaker: Dr. Yongfei Yang, VP, Antibody Research Institute at Biocytogen Nanobodies are a novel class of therapeutic proteins. Significantly smaller than conventional antibodies, they consist only of the antigen-binding region of the heavy chain and offer unique advantages in drug discovery. In this webinar, Dr. Yongfei Yang will delve into the exceptional properties of nanobodies, […]
Read more
Advances in Neurological Disease Animal Models
Speaker: Dr. Dong Han, Sr. Scientist, Neurological Disease Team Lead at Biocytogen Neurological disorders affect over 3 billion people globally, encompassing a wide range of conditions that impact the brain, spinal cord, and peripheral nerves. Key examples include Alzheimer’s disease, Parkinson’s disease, autism spectrum disorders, and amyotrophic lateral sclerosis. These disorders significantly impair cognitive, emotional, […]
Read more
Advancing IBD Treatment: Leveraging Innovative Models and Therapies for Enhanced Drug Development
Speaker: Dr. Luo (Jack) Jia, Sr. Scientist/Study Director, Team Lead for Disease Modeling at Biocytogen Inflammatory Bowel Disease (IBD) is a chronic autoimmune disorder in which the body’s immune system triggers inflammation in the gastrointestinal tract. Affecting nearly one in 100 people in the United States, IBD presents significant challenges for treatment development due to […]
Read more
Empowering Discovery and Development of Bispecific ADCs With a Common Light Chain Antibody Library and a Novel Linker/Payload
Speaker: W. Frank An, PhD. Sr. Director of Antibody Therapeutics, Biocytogen Institute for Therapeutic Innovations, Biocytogen Pharmaceuticals About the webinar: Bispecific ADCs are a growing trend in the ADC field, offering improved efficacy and safety for the treatment of heterogeneous solid tumors. Designing bsADCs requires careful selection of targets, and is not without challenges, including the […]
Read moreWebinar Categories
- Humanized Animal Models
- Others
- Renbiologics
